Menu Back toGlobal Regulatory Strategy and Drug Development in Asia-Pacific, Latin America, and Other Emerging Markets

Global Regulatory Strategy and Drug Development in Asia-Pacific, Latin America, and Other Emerging Markets

NEW OFFERING! This intermediate course will provide practical real-world, actionable information on the nature and development of global regulatory strategies for drug development, with a focus on markets located outside the US and Europe.


Overview

This intermediate course will provide participants practical real-world, actionable information on the nature and development of global regulatory strategies for drug development, with a focus on markets located outside the United States and Europe. Descriptions of the local regulatory environments and requirements for drug development will be enhanced by case examples and by practical experiences in Asia Pacific, Latin America, Africa, and other Emerging Markets.

What you will learn

  • Global regulatory strategy considerations and construction
  • Unique challenges outside the United States and the European Union
  • Regulatory environments and communications with regulators in diverse world markets
  • Overview of Japan, China, Asia Pacific markets, Latin America, and other emerging markets

Who should attend?

Pharmaceutical Professionals with an interest in global regulatory requirements in the areas of:

  • Regulatory affairs
  • Clinical development
  • Research and development
  • Medical
  • Commercialization and Market Access
  • Project managers

Learning objectives

At the conclusion of this course, participants will be able to:

  • Discuss building global drug regulatory strategy including how to develop one in the context of global project teams
  • Compare the unique and diverse challenges of working with different regulatory environments, regulators, and cultures
  • Determine optimal ways of communicating effectively with drug regulatory authorities located outside the United States and Europe
  • List the fundamental regulatory requirements for drug development and approval in Japan, China, other significant Asia Pacific markets, Latin America, and other emerging markets

Participants will complete a knowledge check at the end of the course and will be provided with feedback to ensure learning objectives are attained.


Plan Your Team's Professional Development

Why not take advantage and train your whole department (or even across different departments!) and benefit from increased:

  • Focus
  • Flexibility
  • Convenience
  • Cost Effectiveness

For more information please contact EMEA@DIAglobal.org

Contact us



Registration Questions

Send Email
+41 61 225 51 51


Agenda and Logistics

Send Email
+41 61 225 51 55